Showing results (271-280 of 380) with videos related to
Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with IpilimumabAlexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.Journal for Immunotherapy of Cancer|September 22, 2025
ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancerKatharina Lindner, Saskia R Stange, Julian Benedikt Hlawatsch, et al.Frontiers of Medicine|July 11, 2023
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trialElias A T Koch, Anne Petzold, Anja Wessely, et al.Scientific Reports|August 4, 2025
Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositisMagdalena Röckel, Luca Musella, Corinna Preusse, et al.Journal of the National Cancer Institute|September 14, 2014
TERT promoter mutation status as an independent prognostic factor in cutaneous melanomaKlaus G Griewank, Rajmohan Murali, Joan Anton Puig-Butille, et al.The Journal of Dermatology|April 11, 2020
Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective studyTaisuke Matsuya, Yasuhiro Nakamura, Shigeto Matsushita, et al.International Journal of Molecular Sciences|March 25, 2022
The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint InhibitionLuca Hegedüs, Elisabeth Livingstone, Ágnes Bánkfalvi, et al.Oncotarget|September 2, 2015
Analysis of SDHD promoter mutations in various types of melanomaSimone L Scholz, Susanne Horn, Rajmohan Murali, et al.Cancers|May 14, 2022
Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient SurvivalCarl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.European Journal of Cancer (Oxford, England : 1990)|November 20, 2018
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitorsAlvaro Moreira, Carmen Loquai, Claudia Pföhler, et al.Pageof 38